Law360, New York (July 2, 2007, 12:00 AM EDT) -- In a recent public announcement, Johnson & Johnson disclosed that it may have violated the Foreign Corrupt Practices Act and had reported potential violations to the Department of Justice and the Securities and Exchange Commission. Johnson & Johnson’s disclosure highlights the risks of FCPA violations for the medical device industry.
It also reflects a broader trend of increased FCPA enforcement, as do recent cases involving multimillion dollar fines.
*Risks for medical device industry*
Medical device companies are particularly at risk with respect to FCPA violations. In...
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.